بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), linear decrease (توسيع البحث), clinical areas (توسيع البحث)
clinical case » clinical cases (توسيع البحث), clinical care (توسيع البحث), clinical course (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), linear decrease (توسيع البحث), clinical areas (توسيع البحث)
clinical case » clinical cases (توسيع البحث), clinical care (توسيع البحث), clinical course (توسيع البحث)
-
541
-
542
-
543
-
544
Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
545
Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
546
Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
547
Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
548
Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
549
Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
550
Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
551
Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
552
-
553
-
554
Decreased childhood asthma hospitalizations linked to hotter, drier climate with lower wind speed in drylands
منشور في 2025"…A generalized additive model analyzed the association between these trends, and the Mann-Kendall test determined if trends were increasing, decreasing, or not significant. Thirteen municipalities showed a significant link between hospitalizations and climate variables, especially wind speed, maximum temperature, and humidity. …"
-
555
Statistically significant linear increase in use of antidepressants during the observed time period.
منشور في 2025الموضوعات: -
556
-
557
-
558
<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation.
منشور في 2025"…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …"
-
559
-
560